Efficacy and Safety of Split-dose Citrafleet Administered From 2 to 6 Hours Before Morning Colonoscopies
Sponsored by Infante, Javier Molina, M.D.
About this trial
Last updated 14 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 13 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- all patients undergoing routine elective colonoscopy
Exclusion Criteria
- pregnant or lactating women
- age less than 18 years
- significant gastroparesis or gastric outlet obstruction or ileus
- known or suspected bowel obstruction or perforation
- phenylketonuria or glucose-6-phosphate dehydrogenase deficiency
- severe chronic renal failure (creatinine clearance < 30 mL/minute)
- severe congestive heart failure (New York Heart Association [NYHA] class III or IV)
- dehydration
- severe acute inflammatory disease
- compromised swallowing reflex or mental status
- uncontrolled hypertension (systolic blood pressure > 170 mm Hg ad/or diastolic blood pressure > 100 mm Hg)
- toxic colitis
- megacolon